A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable
Clinical trial NCT02755649 · COMPLETED
Trial details
- NCT number
- NCT02755649
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-31
- Primary completion
- 2017-01-04
- Enrollment
- 325
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.